Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,874,438
-$7,154,970 QoQ
Shares Held
2,336,528
-9.3% QoQ
Ownership
2.78%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. REPL ranks #45 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in REPL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,874,438 | 2,336,528 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,029,408 | 2,575,042 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,690,643 | 403,495 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,706,276 | 506,596 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,766,654 | 796,580 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,777,882 | 972,575 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,509,805 | 867,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,386,020 | 931,780 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,151,910 | 997,786 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,048,539 | 243,006 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,380,828 | 80,703 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,033,654 | 87,582 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,404,214 | 136,139 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,507,956 | 128,969 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $321,295 | 18,922 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $3,699,551 | 121,257 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,088,115 | 107,159 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $644,467 | 27,996 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||